Defining the target for radiotherapy of head and neck cancer

Cancer Imaging

Volumn 7, Issue SPEC. ISS. A, 2007, Pages

  Nuyts, Sandra ^a  

^a Katholieke Universiteit   (Belgium)

Author keywords

Head and neck cancer; Imaging; Radiotherapy

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; FLUORODEOXYGLUCOSE;

ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; HEAD AND NECK CANCER; HUMAN; IMAGE RECONSTRUCTION; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; TREATMENT PLANNING; TUMOR VOLUME; ARTIFACT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEAD AND NECK TUMOR; PATHOLOGY; REVIEW; THREE DIMENSIONAL IMAGING;

ARTIFACTS; HEAD AND NECK NEOPLASMS; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35848960348     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2007.9009     Document Type: Article

References (20)

1. Hermans R, Feron M, Belton E, et al. Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. Int J Radiat Oncol Biol Phys 1998; 40: 553-7.
2. Eisbruch A. Foote RL, O'Sullivan B, et al. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol 2002; 12: 238-49.
3. Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003; 69: 227-36.
4. Chao C, Wippold FJ, Ozyigit G, et al. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002; 53: 1174-84.
5. Rash C, Keus R, Pameijer FA, et al. The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1997; 39: 841-8.
6. Enami B, Sethi A, Petruzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003; 57: 481-8.
7. Chung N, Ting L, Hsu W, et al. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck 2004; 26: 241-6.
8. 18F-FDG PET/CT in head and neck tumours. Br J Cancer 2005; 92: 1046-50.
9. Scarfone C, Lavely WC, Cmelak AJ, et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 2004; 45: 543-52.
10. Koshy M, Paulino AC, Howell R, et al. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck 2005; 27: 494-502.
11. Paulino AC Koshy M, Howell R, et al. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005; 61: 1385-92.
12. Ciernik FI, Dizendorf E, Baumert B, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT):a feasibility study. Int J Radiat Oncol Biol Phys 2003; 57: 853-63.
13. 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 2002; 53: 1051-7.
14. Schwartz DL, Ford EC, Rajendran J, et al. FDG-PET/CT guided intensity modulated head and neck cancer radiotherapy: a pilot investigation. Head Neck 2005; 27: 478-87.
15. Daisne JF, Duprez T, Weynant B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004; 233: 93-100.
16. 18F]-misonidazolo positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006; 24: 2098-104.
17. Chao C, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001; 49: 1171-82.
18. Hoskin PJ, Saunders MI, Goodchild K, et al. Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol 1999; 72: 1093-8.
19. Rijpkema M, Kaanders JHAM, Joosten FBM, et al. Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2002; 53: 1185-91.
20. Vandecaveye V, De Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys. 2006; 67: 960-71.